Optometry News

TAMPA, Fla. — In a presentation from Telling It Like It Is, Analisa Arosemena, MD, discussed the path to achieving 24/7 IOP control for patients with glaucoma and the role that canaloplasty may play.

Qlaris Bio announced the initiation and dosing of two phase 2 trials aimed at assessing QLS-111, a therapy for lowering intraocular pressure by targeting episcleral venous pressure, or EVP, in patients with glaucoma.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Joan Stauffer, director of marketing and communications for Iridex, discusses new laser systems from the company.

The prevalence of myopic macular degeneration among very old individuals increased nearly ninefold for each millimeter increase in axial length and was strongly associated with vision impairment and blindness, according to a study.

In this Healio Video Perspective, Abigail Markward, MBA, executive director of The American Society of Cataract and Refractive Surgery Foundation, provides an overview of events the foundation will be running during the ASCRS 2024 meeting.

A survey conducted by The Ohio State University Wexner Medical Center found that nearly 30% of Americans do not know that looking directly at a solar eclipse without protection can cause permanent eye damage.

Patients with myopia may qualify for several refractive surgery options depending on their age, lifestyle, corneal health and expectations.

EssilorLuxottica and the World Council of Optometry have announced a global partnership to raise awareness about presbyopia and establish standards of care for management of the condition.

NEW YORK — Topography-guided PRK and CTAK can change the corneal curvature in patients with keratoconus, according to a speaker at Vision Expo East.

The first Canadian patient has been dosed in a phase 1/2 trial of a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release.